Citation Tools

Concise report
Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 5-year results of the GO-RAISE study

Download to a citation manager

Cite this article as:
Deodhar A, Braun J, Inman RD, et al
Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 5-year results of the GO-RAISE study